Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions and is a subsidiary of Crown Equity Holdings Inc. (CRWE)
Crown Tele Services is a leading provider of communications services. Their network utilizes blazing fast fiber optic channels throughout the world with our engineers devoted to guaranteeing the highest quality and reliability possible.
Crown Tele Services goal is to provide the client affordable, world class communication solutions without giving up popular features like call waiting, call forwarding, toll free, voice mail and more.
Crown Tele Services mission is to create lifelong relationships through customer satisfaction, by offering communications solutions designed to fit your business needs while saving you a ton of money. Crown Tele Services is able to offer features to the small business owner previously only available to large enterprise corporations.
Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.
For more information about Crown Tele Services Inc. please visit http://crownteleservices.com
For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com
QuinStreet, Inc. (Nasdaq:QNST), the leader in vertical marketing and media online, reported that Greg O'Brien has joined the company as senior vice president of business development.
Greg brings extensive industry experience and contacts to QuinStreet. He most recently served as chief executive officer of The CollegeBound Network, a provider of online marketing services to the Education industry. Greg also worked previously as chief financial officer of CollegeBound and as an investment banker to media and technology clients.
BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, reported that it has filed a 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) for regulatory clearance of an expanded indication for its BGM Galectin-3 test.
The blood test was cleared by the FDA in November 2010 and is currently indicated for use in patients with chronic heart failure who are at increased risk for hospitalizations or death based on elevated levels of galectin-3. Subject to FDA clearance, the new application would expand the indicated use to the general adult population to identify those with an elevated level of galectin-3, which is associated with an increased risk for new-onset heart failure.
Pluristem Therapeutics, Inc. (Nasdaq:PSTI) reported that cardiac function in a diabetic-induced diastolic dysfunction in animals improved following PLacental eXpanded (PLX cells) administration.
The study was conducted as part of the European Commission's Seventh Framework Program (FP7) in collaboration with Professor Doctor Carsten Tschope and his staff at the Charite Universitaetsmedizin Berlin, Berlin-Bradenburg Center for Regenerative Therapies (BCRT), Berlin, Germany. Dr. Tschope is also a member of the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
Sign Up for Free Stock Newsletter at http://www.pennyotcstock.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.